Publications

John Vella, MD

  1. Little D, Gleeson M, Baluch W, Farrell J, Vella JP, Donohoe J, Murphy D and Hickey D: Treatment of type 1 Diabetes Mellitus by simultaneous pancreatic kidney transplantation - the Beaumont Hospital Experience. J Irish Col Physicians Surgeons, V23 No.3 July, 1994.
  2. Vella JP, Carmody M, Campbell E, Browne O, Doyle G, Donohoe J: Glomerulonephritis after ventriculo-atrial shunt. Q J Med, 88:911-918, 1995.
  3. Vella JP, Leavey S, Farrell J, Carmody M and Walshe JJ. Rapid reversal of profound hypothermia using peritoneal dialysis. Irish J Med Sci, 165(3):113-114, 1996.
  4. Vella JP, Doyle GD and Carmody M. Metachronous Transitional Cell Carcinoma and Tubulointerstital Nephritis after Chronic Ingestion of Antacids: A novel disease association. Nephrol Dial Transplantation, 11:2367-2368, 1996.
  5. Vella JP, Doyle GD, Campbell E, Walshe JJ: Light Chain Deposition Disease Complicating Familial Mediterranean Fever. Am J Kidney Dis, 29(6):942-946, 1997.
  6. Vella JP, Mosher R, Sayegh MH: Kaposi's Sarcoma post Transplantation. N Engl J Med, 336(24):1761, 1997.
  7. Vella JP, O'Callaghan J, Hickey D, Walshe JJ: Renal Artery Stenosis Complicating Cogan's Syndrome. Clin Nephrol, 47(6):407-408, 1997.
  8. Vella JP, Sayegh MH: Maintenance Pharmacological Immunosuppressant Strategies in Renal Transplantation. Postgrad Med J, 73(6):386-390, 1997.
  9. Little DM, Burke PE, O'Callaghan J, Vella JP, Donohoe J, Hickey DP: Renal Revascularisation by Gastroduodenal-renal Bypass as Treatment of Renal Artery Stenosis. Ir Med J, 90(1):23-24, 1997.
  10. Vella JP, Ferreira M, Murphy B, Alexander SI, Harmon W, Carpenter CB, Sayegh MH: Indirect Allorecognition of MHC Allopeptides in Human Renal Transplant Recipients with Chronic Graft Dysfunction. Transplantation, 64(6):795-800, 1997.
  11. Vella JP, Sayegh MH: Current and Future Immunosuppressive Therapies: Impact on Chronic Allograft Dysfunction; J Nephrol, 10(5):229-231, 1997.
  12. Vella JP, Vos L, Sayegh MH: The Role of Indirect Allorecognition in Experimental Delayed Acute Rejection. Transplantation, 64(12):1823-1829, 1997.
  13. Vella JP, Sayegh MH: Interactions Between Cyclosporine and Newer Antidepressant Medications. Am J Kidney Dis, 31:320-323, 1998.
  14. Schaub M, Stadlbauer T, Chandraker A, Vella JP, Turka LA, Sayegh MH: Comparative Strategies to Induce Long term Graft Acceptance in Fully Allogeneic Renal Versus Cardiac Allograft Models by CD28-B7 T Cell Costimulatory Blockade: Role of Thymus and Spleen. J Amer Soc Nephrol, 9(5):891-898, 1998.
  15. Vella JP, Knoflach A, Sayegh MH: T Cell Mediated Immune Responses in Chronic Allograft Rejection: Role of Indirect Allorecognition and Costimulatory Pathways. Graft, 1(2)Suppl II:11-17, 1998.
  16. Magee C, Vella JP, Tormey WP, Walshe JJ: Multiple myeloma and Renal Failure: One Center’s Experience. Renal Failure, 20(4):597-606, 1998.
  17. Vella JP, Sayegh MH, Turka LA. Developments in the Science Of Transplantation During the 20th Century. Pediatric Transplantation, 2(4):257 - 262, 1998.
  18. Vella JP, O'Neill D, Atkins N, Donohoe J.F, Walshe J: Sensitization to Human Leukocyte Antigen Before and After the Introduction of Erythropoietin. Nephrol Dial and Transplant, 13(8):2027-32, 1998.
  19. Murphy B, Magee C, Alexander SI, Waaga AM, Snoeck H, Vella JP, Carpenter CB, Sayegh MH: Inhibition of Allorecognition by a Human Class II MHC Derived Peptide Through the Induction of Apoptosis. J Clin Invest, 103(6):859-867, 1999.
  20. McDermott MF, Aksentijevich I, Galon J, McDermott E, Ogunkolade BW, Centola M, Mansfield E, Gadina M, Karenko L, Pettersson T, McCarthy J, Frucht DM, Aringer M, Torosyan Y, Teppo AM, Wilson M, Raatikainen M, Wan T, Todd I, Wood G, Schlimgen R, Kumarajeewa TR, Cooper SM, Vella JP, Amos C, Mulley J, Quane KA, Molloy G, Ranki A, Powell RJ, Hitman GA, O'Shea JJ, Kastner DL: Germline Mutations in the Extracellular Domains of the 55 kDa TNF Receptor (TNFR1) Define a Family of Dominantly Inherited Autoinflammatory Syndromes. Cell, 97:133-144, 1999.
  21. Vella JP, Magee C, Vos L, Womer K, Rennke H, Carpenter CB, Hancock W, Sayegh MH: Cellular and humoral mechanisms of vascularized allograft rejection induced by indirect recognition of donor mhc allopeptides. Transplantation, 67:1-10, 1999.
  22. Vella JP, Stadlbauer THW, Schaub M, Sayegh MH. Immune Tolerance. In Hakim, Danovitch and Hoyer eds Transplantation Surgery. Springer, London 2000: 73-91.
  23. Womer K, Vella JP, Sayegh MH. Chronic Allograft Dysfunction: Mechanisms and Newer Approaches to Management. Seminars Nephrology 2000; 20:126-137.
  24. Waaga AM, Gasser M, Kist-Van Holthe JE, Najafian N, Muller A, Vella JP, et al, Regulatory functions of self-restricted MHC Class II allopeptide-specific Th2 clones in vivo. J Clin Invest 2001; 107(7):909-16.
  25. Vannorsdall M,Thomas S, Smith RP, Zimmerman R, Christman R, Vella JP. "Human granulocytic ehrlichiosis in a renal allograft recipient: review of the clinical spectrum of disease in solid organ transplant patients". Transpl Inf Dis 2002 4:97-101
  26. Opolinsky D, Vella JP. Successful Conversion to Sirolimus is Associated with a Good Outcome in Calcineurin Inhibitor-Induced Thrombotic Microangiopathy in Renal Allograft Recipients. Am J Trans. In press
  27. Harris S, Himmelfarb J, Vella JP. Prospective evaluation of T cell subsets and peripheral blood cytokines in renal transplantation: differential effects of alternate immunosuppressive protocols. AJT 2004. In Press
  28. Vella JP. Significance of anticardiolipin antibodies on short and long term allograft survival and function following kidney transplantation. Am J Transplant 2004:4; 1731
  29. Simmons EM, Langone A, Sezer MT, Vella JP, Recupero P, Morrow JD, Ikizler TA, Himmelfarb J. Effect of renal transplantation on biomarkers of inflammation and oxidateive stress in ESRD patients. Transplantation 2005;79
  30. Bennett W, Vella JP. Transplantation NephSAP. J Am Soc Nephrol Vol 4, No.1: Jan 2005